Skip to main content

S. 1897

Referred to Committee

A bill to establish a process for updating the labeling of certain drugs with outdated labeling.

Introduced 6/19/2019•116th Congress•Senate

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

6/19/2019 • Senate

Summary

This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.

Introduced in Senate • 6/19/2019

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Congressional oversightDrug safety, medical device, and laboratory regulationPrescription drugs

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (2)

Party Breakdown

1
Democrats
1
Republicans
0
Independents

Sponsor

S[
Sen. Bennet, Michael F. [D-CO]

Democrat • CO

Sponsored 6/19/2019

Cosponsors (1)

S[
Sen. Enzi, Michael B. [R-WY]

R-WY

Joined 6/19/2019

Bill Journey

Originated in the Senate

Introduced

June 19, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate6/19/2019

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors1